Dermatology
From the Journals
International panel backs energy-based devices as first-line treatment of acne scars
A panel of 24 international experts in dermatology and plastic surgery assembled to develop the recommendations for integrating EBDs into the...
From the Journals
Dust mite immunotherapy may help some with eczema
In a study, 74.2% and 58% of patients in HDM SLIT and placebo groups, respectively, showed at least a15-point decrease in SCORAD, but those...
From the Journals
Care via video teleconferencing can be as effective as in-person for some conditions
Video teleconferencing works best for monitoring patients with chronic conditions, according to the author of a new paper.
From the Journals
Guselkumab’s efficacy, safety confirmed in patients with psoriatic arthritis and prior TNFi exposure
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that “people who’ve previously failed a TNF inhibitor might be...
Conference Coverage
Two questions can help establish a diagnosis of hidradenitis suppurativa
There is no perfect outcome measure yet, but progress is being made.
Conference Coverage
Certain opioids hold promise for treating itch
Difelikefalin is the first FDA-approved treatment for uremic pruritus associated with dialysis.
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
From the Journals
Prevalence of undiagnosed vitiligo is ‘remarkably high’
Current overall prevalence among adult population estimated at 1.9 million to 2.8 million in the United States.
Conference Coverage
Rosacea is in the eye of the beholder, expert says
As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.
Latest News
Microbiome studies among those awarded National Rosacea Society grants
Projects earning grants in 2021 include those on the ocular microbiome and genetic sequencing of Demodex mites.
Conference Coverage
Topical options for acne patients continue to expand
In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and...